NCT06679049 Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing
| NCT ID | NCT06679049 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Tibial Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-04-30 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-04-30 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this study is to perform a high-quality randomized control trial comparing intramedullary tibial nail fixation with standard design nails to a micromotion tibial nail device, to evaluate the rates of union and post-operative outcomes.
Eligibility Criteria
Inclusion Criteria: * Age 18 - 85 years * Stable Tibial fracture recommended for surgical intervention Exclusion Criteria: * Patients not meeting inclusion criteria * Unstable fracture patterns e.g. those needing a secondary intervention - masquelet/cement spacer) * Previously non-ambulatory patients * Delayed presentation of fracture (\>4 weeks) * Fractures that the treating surgeon indicates requires additional fixation strategies to achieve stability * Patients with an achieve infection or wound at the surgical site * Any previous ligament or fracture surgery on the index site * Inflammatory rheumatic disease or other rheumatic disease- * Immune compromised patients (hepatitis, HIV, etc.) * Unwilling or unable to participate or follow study protocol
Contact & Investigator
Joseph Johnson, MD
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06679049 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Tibial Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06679049 currently recruiting?
Yes, NCT06679049 is actively recruiting participants. Contact the research team at jpjohnso@uab.edu for enrollment information.
Where is the NCT06679049 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06679049 clinical trial?
NCT06679049 is sponsored by University of Alabama at Birmingham. The principal investigator is Joseph Johnson, MD at University of Alabama at Birmingham. The trial plans to enroll 100 participants.